Advertisement
Screener

Nabriva Therapeutics plc Form D

Nabriva Therapeutics plc Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2018-07-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-07-24; Total offering amount $26,901,904.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2018-07-27Rule 506(b)Equity2018-07-24$26,901,904$21,301,451$5,600,45367